Researchers concerned about rebound effects after stopping GLP-1 therapies may find this mechanism particularly appealing
Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA (2017) Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility
Binds toxins and heavy metals, aiding their removal from cells
In: Advances in Cancer Research
Zepbound, KwikPen, and LillyDirect are registered trademarks, and Foundayo is a trademark of Eli Lilly and Company
UK guidance on managing GLP-1 medications around surgery is evolving as clinical experience with these agents increases